N-Acetyl-GED-0507-34-Levo corresponding vehicle
Sponsors
PPM Services S.A.
Conditions
Acne Vulgarisacne vulgaris
Phase 3
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)
RecruitingCTIS2023-510339-12-00
Start: 2024-11-11Target: 300Updated: 2026-01-26
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-2)
RecruitingCTIS2023-510341-19-00
Start: 2024-11-14Target: 310Updated: 2025-11-10
A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1)
CompletedNCT07384195
Start: 2024-11-19End: 2026-04-30Updated: 2026-09-15
A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)
CompletedNCT07384208
Start: 2024-11-19End: 2026-05-28Updated: 2026-09-15